AI assistant
Sending…
Dolby Laboratories, Inc. — Director's Dealing 2020
Feb 28, 2020
30828_dirs_2020-02-27_07e30cbc-86de-4dac-ac8c-b2a25f58436d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Dolby Laboratories, Inc. (DLB)
CIK: 0001308547
Period of Report: 2020-02-27
Reporting Person: YEAMAN KEVIN J (Director, President and CEO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-02-27 | Employee Stock Option (Right to Buy) | $68.40 | G | 193175 | Disposed | 2029-12-16 | Class A Common Stock (193175) | Direct |
| 2020-02-27 | Employee Stock Option (Right to Buy) | $68.40 | G | 193175 | Acquired | 2029-12-16 | Class A Common Stock (193175) | Indirect |
Footnotes
F1: Effective February 27, 2020 the Reporting Person transferred this option to a revocable trust for no consideration, for estate planning purposes.
F2: This option was granted for a total of 193,175 shares of Class A Common Stock. 1/4 of the total number of shares issuable under the option vests on the first anniversary of December 16, 2019, the vesting commencement date, and the balance of the shares in equal monthly installments over the next 36 months thereafter.
More from Dolby Laboratories, Inc.
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
Apr 30
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Feb 27
Director's Dealing
2026
Feb 18
Director's Dealing
2026
Feb 17
Director's Dealing
2026
Feb 13
Major Shareholding Notification
2026
Feb 13
Director's Dealing
2026
Feb 9
Regulatory Filings
2026
Feb 6